Citigroup
TYRA icon

Citigroup’s Tyra Biosciences TYRA Stock Holding History

Citigroup’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$229K Buy
5,991
+2,174
+57% +$70.4K ﹤0.01% 3946
2025
Q4 		$100K Buy
3,817
+2,110
+124% +$38.8K ﹤0.01% 4323
2025
Q3 		$23.9K Sell
1,707
-7,790
-82% -$88.8K ﹤0.01% 4767
2025
Q2 		$90.9K Sell
9,497
-6,010
-39% -$57.1K ﹤0.01% 4452
2025
Q1 		$144K Sell
15,507
-1,296
-8% -$16.8K ﹤0.01% 4387
2024
Q4 		$234K Buy
16,803
+2,136
+15% +$38.8K ﹤0.01% 4326
2024
Q3 		$345K Buy
14,667
+10,234
+231% +$215K ﹤0.01% 3977
2024
Q2 		$70.9K Sell
4,433
-2,673
-38% -$46K ﹤0.01% 4393
2024
Q1 		$117K Buy
7,106
+5,075
+250% +$83.2K ﹤0.01% 4229
2023
Q4 		$28.1K Buy
2,031
+2,012
+10,589% +$26K ﹤0.01% 4847
2023
Q3 		$262 Sell
19
-4,146
-100% -$61.5K ﹤0.01% 5287
2023
Q2 		$70.9K Buy
+4,165
New +$60.4K ﹤0.01% 4423
2023
Q1 		– Sell
-89
Closed -$676 – 5867
2022
Q4 		$676 Sell
89
-111
-56% -$785 ﹤0.01% 5465
2022
Q3 		$2K Sell
200
-734
-79% -$6.71K ﹤0.01% 5540
2022
Q2 		$7K Buy
934
+475
+103% +$3.78K ﹤0.01% 5514
2022
Q1 		$5K Sell
459
-2,706
-85% -$32.1K ﹤0.01% 5841
2021
Q4 		$45K Buy
3,165
+2,725
+619% +$54.1K ﹤0.01% 5122
2021
Q3 		$8K Buy
+440
New +$8.41K ﹤0.01% 5526

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Citigroup's TYRA Position: Q1 2026 in Review

Citigroup increased its Tyra Biosciences (TYRA) stake by 57% in Q1 2026, buying an estimated $70.4K and bringing the position to 5,991 shares worth $229K. The position accounts for ﹤0.01% of the portfolio, ranked #3946.

Citigroup first reported a position in TYRA in Q3 2021 and has held it in 18 quarters since. The position peaked at $345K in Q3 2024. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • Citigroup held 5,991 shares of Tyra Biosciences worth $229K as of Q1 2026.
  • Citigroup bought 2,174 Tyra Biosciences shares in Q1 2026, an estimated $70.4K.
  • Tyra Biosciences made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #3946 holding.
  • Citigroup first reported a position in Tyra Biosciences in Q3 2021 and has held it in 18 quarters since.
  • Citigroup's Tyra Biosciences position peaked at $345K in Q3 2024.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.